Look for:

Products

GRIFOLS SA


ISIN:
ES0171996087
WKN:
-
2024/04/19 17:35:17
Price
8.346 EUR
Difference -3.16% (-0.27)

General attributes

ISINES0171996087
SymbolGRF
ExchangeBME Continuous Market
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)5,104 EUR
BenchmarkIBEX 35

Market data

Bid (Bid size)-
Ask (Ask size)-
Open8.45 EUR
High8.482 EUR
Low8.22 EUR
Close (prev. day)8.618 EUR
VWAP8.363599 EUR
Volume (pcs)3,288,156
Trading volume27,500,818.88
Number of trades5,307
Last size10,395

Futures and Options

Related Futures38
Related Options-

PDF Downloads

Company report: GRIFOLS SAPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/19 17:35:17
Price
8.346 EUR
Difference -3.16% (-0.27)

General attributes

ISINES0171996087
SymbolGRF
ExchangeBME Continuous Market
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)5,104 EUR
BenchmarkIBEX 35

Market data

Bid (Bid size)-
Ask (Ask size)-
Open8.45 EUR
High8.482 EUR
Low8.22 EUR
Close (prev. day)8.618 EUR
VWAP8.363599 EUR
Volume (pcs)3,288,156
Trading volume27,500,818.88
Number of trades5,307
Last size10,395

Performance and Risk

6m1Y3Y
Perf (%)-22.11%-11.42%-63.99%
Perf (abs.)-2.37-1.08-14.83
Beta2.661.891.04
Volatility103.6376.9455.90
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)8.614 EUR (2,253,134)
Ø price 30 days | Ø volume 30 days (pcs.)8.360 EUR (4,727,914)
Ø price 100 days | Ø volume 100 days (pcs.)10.578 EUR (4,029,198)
Ø price 250 days | Ø volume 250 days (pcs.)11.424 EUR (2,376,448)
YTD High | date15.630 EUR (2024/01/02)
YTD Low | date6.362 EUR (2024/03/06)
52 Weeks High | date15.920 EUR (2023/12/29)
52 Weeks Low | date6.362 EUR (2024/03/06)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2024/04/1809:058.832 EUR0.003
Tradegate2024/04/1922:268.218 EUR0.1144
Stuttgart2024/04/1908:058.378 EUR0.003
Munich2024/04/1908:148.584 EUR0.002
London Stock Exchange European Trade Reporting2024/04/1917:308.388 EUR0.002
Hanover2024/04/1908:018.47 EUR0.003
Frankfurt2024/04/1908:268.47 EUR0.002
FINRA other OTC Issues2024/03/1215:438.46 USD0.014
Duesseldorf2024/04/1919:318.232 EUR0.007
Berlin2024/04/1921:508.218 EUR0.0018
BME Continuous Market2024/04/1917:358.346 EUR27.505,307

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=11140&ID_TYPE_IMAGE_LOGO=2

Contact Details

GRIFOLS SA
- -
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan - 08174 Barcelona
Telefon: +34-93-571-02-21
Fax: +34-93-571-02-67
E-mail: -

PDF Downloads

Company report: GRIFOLS SAPDF Download

Company Profile

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Members of Management Board

Thomas GlanzmannChairman of Managing Board
Raimon Grifols RouraMember of Executive Committee
Víctor Grífols DeuMember of Executive Committee

Board of directors

Thomas Heinrich GlanzmannChairman of Supervisory Board
Enriqueta Felip FontMember of Supervisory Board
Albert Coma-CrosMember of Supervisory Board
Carina Szpilka LázaroMember of Supervisory Board
James CostosMember of Supervisory Board
Montserrat Muñoz AbellanaMember of Supervisory Board
Raimon Grifols RouraMember of Supervisory Board
Susana González RodríguezMember of Supervisory Board
Tomás Dagá GelabertMember of Supervisory Board
Victor Grifols DeuMember of Supervisory Board
Íñigo Sánchez-Asiaín MardonesMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.